These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Naltrexone in the treatment of alcohol dependence. Volpicelli JR; Alterman AI; Hayashida M; O'Brien CP Arch Gen Psychiatry; 1992 Nov; 49(11):876-80. PubMed ID: 1345133 [TBL] [Abstract][Full Text] [Related]
46. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms. Kampman KM; Dackis C; Lynch KG; Pettinati H; Tirado C; Gariti P; Sparkman T; Atzram M; O'Brien CP Drug Alcohol Depend; 2006 Nov; 85(2):129-37. PubMed ID: 16697124 [TBL] [Abstract][Full Text] [Related]
47. A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependence. Somoza EC; Winship D; Gorodetzky CW; Lewis D; Ciraulo DA; Galloway GP; Segal SD; Sheehan M; Roache JD; Bickel WK; Jasinski D; Watson DW; Miller SR; Somoza P; Winhusen T JAMA Psychiatry; 2013 Jun; 70(6):630-7. PubMed ID: 23575810 [TBL] [Abstract][Full Text] [Related]
48. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial. Collins ED; Kleber HD; Whittington RA; Heitler NE JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380 [TBL] [Abstract][Full Text] [Related]
49. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy. Feeney GF; Connor JP; Young RM; Tucker J; McPherson A Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406 [TBL] [Abstract][Full Text] [Related]
50. Bupropion hydrochloride versus placebo, in combination with cognitive behavioral therapy, for the treatment of cocaine abuse/dependence. Shoptaw S; Heinzerling KG; Rotheram-Fuller E; Kao UH; Wang PC; Bholat MA; Ling W J Addict Dis; 2008; 27(1):13-23. PubMed ID: 18551884 [TBL] [Abstract][Full Text] [Related]
51. Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexone. Sullivan MA; Bisaga A; Glass A; Mishlen K; Pavlicova M; Carpenter KM; Mariani JJ; Levin FR; Nunes EV Drug Alcohol Depend; 2015 Feb; 147():122-9. PubMed ID: 25555621 [TBL] [Abstract][Full Text] [Related]
52. Medical treatments for opioid use disorder in Iran: a randomized, double-blind placebo-controlled comparison of buprenorphine/naloxone and naltrexone maintenance treatment. Mokri A; Chawarski MC; Taherinakhost H; Schottenfeld RS Addiction; 2016 May; 111(5):874-82. PubMed ID: 26639678 [TBL] [Abstract][Full Text] [Related]
53. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial. McDowell D; Nunes EV; Seracini AM; Rothenberg J; Vosburg SK; Ma GJ; Petkova E Drug Alcohol Depend; 2005 Nov; 80(2):209-21. PubMed ID: 15913920 [TBL] [Abstract][Full Text] [Related]
54. A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence. Kampman KM; Lynch KG; Pettinati HM; Spratt K; Wierzbicki MR; Dackis C; O'Brien CP Drug Alcohol Depend; 2015 Oct; 155():105-10. PubMed ID: 26320827 [TBL] [Abstract][Full Text] [Related]
55. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial. Guardia J; Caso C; Arias F; Gual A; Sanahuja J; Ramírez M; Mengual I; Gonzalvo B; Segura L; Trujols J; Casas M Alcohol Clin Exp Res; 2002 Sep; 26(9):1381-7. PubMed ID: 12351933 [TBL] [Abstract][Full Text] [Related]